trending Market Intelligence /marketintelligence/en/news-insights/trending/kht0vpmqruyevooe_2g_gg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Billionaire Jack Ma's Yunfeng Capital, Alibaba to take iKang Healthcare private

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Billionaire Jack Ma's Yunfeng Capital, Alibaba to take iKang Healthcare private

IKang Healthcare Group Inc. will go private after being acquired by two entities owned by Chinese billionaire Jack Ma.

Private equity firm Yunfeng Capital and e-commerce giant Alibaba Group Holding Ltd. entered definitive agreements to buy the Beijing-based healthcare services provider for $41.20 per common share or $20.60 for every American depositary stock acquired.

Jack Ma is the co-founder of both Yunfeng Capital and Alibaba.

IKang will be delisted from Nasdaq once the acquisition goes through, expected in the third quarter of the year.

J.P. Morgan Securities (Asia Pacific) Ltd., Simpson Thacher & Bartlett LLP, Walkers and Junhe LLP advised the iKang board on the deal. Davis Polk & Wardwell LLP and King & Wood Mallesons are serving as legal counsel to iKang.

Wilson Sonsini Goodrich & Rosati and Fangda Partners are serving as legal counsel to the buyers.